Current status: 967 hESC lines, 5572 hiPSC lines, and 136 clinical studies, and 1934 certificates
Monthly statistic from Mar 1, 2024
Posted on March 1, 2024
| total lines | 6539 |
| hESC lines | 967 |
| hiPSC lines | 5572 |
| derivation countries | 46 |
| projects | 293 |
| providers | 883 |
| clinical studies | 136 |
| subclones | 2619 |
| certificates | 1934 |
| cell line certificates | 1790 |
| project certificates | 144 |